Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis

Abstract

Objective To assess whether weight loss interventions for adults with obesity affect all cause, cardiovascular, and cancer mortality, cardiovascular disease, cancer, and body weight. Design Systematic review and meta-analysis of randomised controlled trials (RCTs) using random effects, estimating risk ratios, and mean differences. Heterogeneity investigated using Cochran’s Q and I2 statistics. Quality of evidence assessed by GRADE criteria. Data sources Medline, Embase, the Cochrane Central Register of Controlled Trials, and full texts in our trials’ registry for data not evident in databases. Authors were contacted for unpublished data. Eligibility criteria for selecting studies RCTs of dietary interventions targeting weight loss, with or without exercise advice or programmes, for adults with obesity and follow-up ≥1 year. Results 54 RCTs with 30 206 participants were identified. All but one trial evaluated low fat, weight reducing diets. For the primary outcome, high quality evidence showed that weight loss interventions decrease all cause mortality (34 trials, 685 events; risk ratio 0.82, 95% confidence interval 0.71 to 0.95), with six fewer deaths per 1000 participants (95% confidence interval two to 10). For other primary outcomes moderate quality evidence showed an effect on cardiovascular mortality (eight trials, 134 events; risk ratio 0.93, 95% confidence interval 0.67 to 1.31), and very low quality evidence showed an effect on cancer mortality (eight trials, 34 events; risk ratio 0.58, 95% confidence interval 0.30 to 1.11). Twenty four trials (15 176 participants) reported high quality evidence on participants developing new cardiovascular events (1043 events; risk ratio 0.93, 95% confidence interval 0.83 to 1.04). Nineteen trials (6330 participants) provided very low quality evidence on participants developing new cancers (103 events; risk ratio 0.92, 95% confidence interval 0.63 to 1.36). Conclusions Weight reducing diets, usually low in fat and saturated fat, with or without exercise advice or programmes, may reduce premature all cause mortality in adults with obesity. Systematic review registration PROSPERO CRD42016033217.

Effect of lorcaserin in different age groups: a post hoc analysis of patients from the BLOOM, BLOSSOM and BLOOM‐DM studies

“…From this analysis, it is not clear what factors would be responsible for driving greater weight loss in older patients. Notably, overall discontinuation results appeared to be lower for older patients in this analysis and therefore one could speculate that improved adherence could lead to improved weight loss outcomes . Improved weight loss outcomes for older patients has been noted previously in the literature .…”

“…Notably, overall discontinuation results appeared to be lower for older patients in this analysis and therefore one could speculate that improved adherence could lead to improved weight loss outcomes . Improved weight loss outcomes for older patients has been noted previously in the literature . For example, a systematic meta‐analysis of randomized controlled trials evaluating weight loss interventions found some evidence that participants aged 60 or over lost more weight than younger participants .…”

Causality between non‐alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes: A meta‐analysis with bias analysis

“…In line with this hypothesis, the relationship between body mass index (which is a good epidemiological surrogate of insulin resistance) and risk of CVD death is non‐linear, both in subjects with and without T2DM . Moreover, dietary interventions aiming at reducing body weight have been recently shown to induce remission of T2DM while so far there is no clear experimental evidence of a reduced risk of CVD following weight loss interventions …”

Change in weight and central obesity by positive airway pressure treatment in obstructive sleep apnea patients: longitudinal data from the ESADA cohort

“…It is important to note that the overall weight reduction of 1.2 kg in obese patients with OSA in the current study is of clinical relevance. According to a recent meta‐analysis of 34 randomized weight loss intervention trials, weight reduction of approximately 3.4 kg was associated with an 18% risk reduction of all‐cause mortality (Ma et al., ). This number corresponded to six deaths fewer per 1,000 participants.…”